Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$2.55 USD
+0.01 (0.39%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.55 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-2.44 | 0.00% |
Earnings Summary
For their last quarter, Moleculin Biotech (MBRX) reported earnings of -$2.23 per share, missing the Zacks Consensus Estimate of -$2.10 per share. This reflects a negative earnings surprise of 6.19%. Look out for MBRX's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$2.44 per share, reflecting a year-over-year increase of 14.39%.
Earnings History
Price & Consensus
Zacks News for MBRX
Moleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studies
MBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services